Detalhe da pesquisa
1.
Engineering a Programmed Death-Ligand 1-Targeting Monobody Via Directed Evolution for SynNotch-Gated Cell Therapy.
ACS Nano
; 18(11): 8531-8545, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456901